Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients



Status:Recruiting
Conditions:Brain Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:6 - 17
Updated:1/6/2019
Start Date:May 7, 2018
End Date:May 7, 2020
Contact:Vittoria Arslan Carlon, MD
Email:arslancv@mskcc.org
Phone:212-639-2680

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Incidence of Neurocognitive Deficits in Patients After Treatment for Retinoblastoma With Multiple Anesthesia Exposures

The purpose of this study is to see if there is a difference between the development of the
brain (neurodevelopment) in children who have been treated for retinoblastoma with multiple
anesthetic exposures, compared with brain development in children who have never had
anesthesia.


Inclusion Criteria:

- Age ≥ 6 and < 17 years old

- Ability to undergo at least one eye examination without anesthesia prior to current
visit

Exclusion Criteria:

- Diagnosis of any secondary disease associated with developmental delay

- History of second cancer diagnosis

- Legal Blindness

- Past surgery of any type, with the exception of enucleation for retinoblastoma

- Past exposure to anesthesia for purposes other than retinoblastoma examination

- More than one anesthesia encounter before diagnosis at MSK

- Past External Beam Radiation for treatment of retinoblastoma

- Past systemic chemotherapy

- Non-native speaker of English; however, children whose parents speak only Spanish will
be included, because the tests for parents are available in Spanish
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center
1275 York Ave
New York, New York 10021
(212) 639-2000
Phone: 212-639-2680
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials